chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Client was vaccinated with pediatric Pfizer at 9:40am. Client denied symptoms other than mild pain at the injection site. At 9:45am, client lost consciousness and fell from a standing position and hit her left cheek and above her eyebrow. Multiple RNs in the clinic responded. The RN and the client's mom rolled the client onto her back and she regained consciousness immediately. Client was tearful and upset. Client reported that her cheek and head hurt. Ice was applied to the cheek (there was redness and swelling, but no bleeding) and juice was provided. Client was oriented and answered questions appropriately. Pupils were equal. Client denied nausea. Clients's mother stated that the client has no history of fainting. At 9:55am, client was moved into a sitting position, which was well tolerated. At 10:00am, client was moved into a chair, which was also well tolerated. Client reported feeling better and drank more juice and had crackers. Client reported that her 'belly hurt' briefly around 10:03am, but this last less than one minute. Before leaving clinic, client reported that she was feeling better, has soreness on her cheek and denied nausea. Client left the clinic at 10:22am.  Client's mother declined EMS services and was provided with education to call their pediatrician if she noticed signs of a concussion (nausea, headache, confusion) or worsening of the pain on the child's cheek. Client's mother verbalized understanding and planned to bring the client home to rest.
Hives arm, foot, legs; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives arm, foot, legs) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced URTICARIA (Hives arm, foot, legs). At the time of the report, URTICARIA (Hives arm, foot, legs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information included benadryl.Concomitant medications were not provided.; Sender's Comments: Based on the current available information and temporal association between the use of mRNA-1273 and the onset of the events, a causal relationship cannot be excluded.
Rash all over torso 48 hours S/P injection  Red  itchy rash on chest: abdomen: lower back  No other symptoms  No fever; no respiratory symptoms
2days p/vax pt exp constipation, high fever-103F lasting 3days; white count down (2600); hosp; tx w/ampicillin/claforan I.V. for 48hr
A report from a health professional via VAERS concerns a 39 year old male. The patient's relevant medical history and concomitant medications were not reported. On an unknown date the patient received FLUMIST QUADRIVALENT (intranasal). The patient [subsequently] experienced influenza and viral pneumonia. The outcome of the events was unknown. The company physician assessed influenza and viral pneumonia to be serious due to medical importance. The company causality was implied yes for both events.
4 am on Tuesday, January 19 awoke to find the top half of vision in my left eye was grayish/black
Sudden onset of severe chills, for at least 90 minutes. Followed by aches and fever(102).
Fever 100.5; chills; pain at injection site; muscle soreness; joint pain; very mild nausea; This is a spontaneous report from a contactable nurse (patient). A 32-year-old female patient (not pregnant) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: 5926710001), intramuscular on 19Dec2020 10:00 at single dose for COVID-19 immunization. Medical history included covid-19. Concomitant medication in two weeks included bupropion, sertraline, ascorbic acid, betacarotene, calcium sulfate, colecalciferol, cyanocobalamin, ferrous fumarate, folic acid, nicotinamide, pyridoxine hydrochloride, retinol acetate, riboflavin, thiamine mononitrate, tocopheryl acetate, zinc oxide (PRENATAL VITAMINS), cetirizine hydrochloride (ZYRTEC), ergocalciferol (VITAMIN D).  The patient previously took minocycline, tetracycline and, amoxicillin; experienced drug hypersensitivity.  The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The COVID-19 vaccine was administered at Hospital.  The patient experienced fever 100.5, chills, pain at injection site, muscle soreness, joint pain, very mild nausea on 20Dec2020 04:30 AM. The patient received paracetamol (TYLENOL) as treatment. The outcome of events was not recovered.
10 days after receiving the Moderna booster, I broke out into hives. My body dealt with a reaction for almost 3 weeks. I was prescribed Allegra at a higher dose, along with high dose course of prednisone. According to my allergist this was vaccine induced dermatographia.
Patient is noticing tingling sensation in both hands, burning and inflammation sensation as well, no swelling or redness reported. Patient stating it is getting better now.
The second vaccination itched and had a mark like a half dollar; The second vaccination itched and had a mark like a half dollar; This is a spontaneous report from a contactable consumer (patient reporting for herself). This consumer reported events for the second and third doses of the Pfizer vaccine. This is the second of the two reports, describing the events for the second dose.  A 78-year-old female patient received the second dose of BNT162B2 (PFIZER BIONTECH COVID-19 VACCINE) via an unspecified route of administration, administered in the left arm (reported as "injected in left arm and was in the shoulder part in the muscle") on 07Apr2021 (batch/lot number: NW6208) at the age of 78 years old, as DOSE 2, SINGLE for COVID-19 immunization. The patient's medical history included Grave's disease (is for thyroid) which she thinks she has had for years. She does not remember diagnosis date. Patient was allergic to antihistamines; she did not have a manufacturer, lot or expiration for the antihistamine she was allergic to. Patient was allergic to red, orange, and pink dye in any medication. She went to an allergy doctor and he could not give her the medications she was allergic to, just a list of things. He said she was allergic to Latex, Tape, Betadine, Penicillin, Reglan, Tramadol, Phenylephrine Topical, Metoclopramide, Low dose aspirin, Azithromycin, Toradol, Oxycodone/Acetaminophen. She can take Tylenol, but it raises her blood pressure. She does not take it and does not have information on the manufacturer, lot or expiration for any of the medications she is allergic to. She does not know the dates she was diagnosed. Concomitant medications included unspecified products which she takes early morning. She stated that she was not on anything that would interfere. She did not have any different medication with this one than the other two. They did not interfere with the other two. No further details were provided. The patient previously took the first dose of BNT162B2 injected in left arm and was in the shoulder part in the muscle on 04Mar2021 (batch/lot number: NW6200) at the age of 77 years old, as DOSE 1, SINGLE for COVID-19 immunization. There were no prior vaccinations within four weeks and no additional vaccines administered on same date of the Pfizer vaccine. The patient reported that her left arm itched terribly where it was real red at during the third (booster) vaccination. The second vaccination itched and had a mark like a half dollar, and it did not itch like the third one did and that was why she did not report it. No relevant tests were taken for the events. Patient reported that she has blood tests every 3 months. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101472577 same reporter/ patient/vaccine; different dose/ different events
Client started having migraines on 03/09/21.  Client continues to experience migraines but is improving everyday.  Client plans to see her medical provider if symptoms do not disappear by 03/15/21.
Pt describes severe sciatic never pain 1 month after receiving covid-19 moderna vaccine. Also complaining of L leg arm pain/numbness and lymph node pain/numbness. She went to ER 3/14 for sciatic and uncontrolled hypertension--tx with hydralazine, morphine and zofran. F/u 3/17 at Family Practice Clinic and there was no complaint of post-vaccine related events.
Rash began approximately 6 hrs after shot given starting at leg, moving up to thigh, eventually at earlobes/ face. Patient c/o itching, redness. Benadryl taken by patient, helped with symptoms.
Initial report received on 18 July 2012 from the Investigator participating in the post-marketing observational surveillance study under the reference number M5A16. A case of pertussis disease in a 15-month-old female subject was identified by the investigator based on review of data from the Electronic Disease Surveillance (EDSS) electronic database. The subject had received 3 doses of PENTACEL; lot number C3872AB received on 16 May 2011, lot number C3911AA received on 25 July 2011 and lot number C3926AC received on 12 September 2011 (routes and sites of administration not reported). The subject developed cold-like symptoms and paroxysmal cough with a whoop on 16 June 2012, approximately nine months after the last dose. The subject also experienced posttussive vomiting and sleep disturbance. Laboratory testing included positive PCR and positive culture on 20 June 2012. Chest x-ray findings were negative for pneumonia. Corrective treatments consisted of azithromycin starting on 22 June 2012 for 5 days. The subject was not hospitalized. At the time of final contact on 09 July 2012, the subject's cough was still persisting. The duration of the cough was reported at that time as 23 days. Investigator causality assessment is not required as per protocol. Documents held by sender: None.
Patient reported feeling very anxious.  Patient stated she has anxiety and was very anxious prior to vaccine.  She stated she cancelled her appointment 2 previous times.  Patient felt shaky.  Vitals checked, patient given crackers and apple juice. She  laid down and stated she felt better after resting. Patient states she is fine to drive home and that she wanted to be outside in the fresh air.
Approximately 35 red spots about 1/4 inch each with a pinhead sized head appeared across stomach and reaching around to back on right and left sides of trunk.  Spots were observed at bedtime,  Not sure when they first appeared.  No itching.  Roof of mouth and gums were sore later in the night and mild headache occurred.  Spots started disappearing on their own over the course of a week.
EXPIRED VACCINE ADMINISTERED; This spontaneous report received from a health care professional concerned an 8 decade old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, expiry: 19-SEP-2021) dose was not reported, administered on 20-SEP-2021 for prophylactic vaccination. No concomitant medications were reported. On 20-SEP-2021, the patient experienced expired vaccine administered. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of expired vaccine administered was not reported. This report was non-serious.
Vaccinee dev a vaginal yeast infect "...about 2 days p/inject" lt deltoid 20JUL90 & 19AUG90 sx treated w/Terazol vaginal suppository & cleared p/2-3 days. Vaccinee plans to take 3rd vax in series.
In February 2023 I developed high blood pressure on 2/24/2023.  I had a follow up on 2/27/2023.  I was sent to labor and delivery and diagnosed with preeclampsia.  My pregnancy was induced and delivered.  Original due date was 3/14/2023 and the baby weighed 6 pounds at delivery.
unusual heavy menstrual bleeding; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date as unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced unusual heavy menstrual bleeding on an unspecified date. Outcome of event was unknown.   Information on lot/batch number has been requested.
Mid to Upper back pain between shoulder blades on both the left and right side.; This is a spontaneous report from a contactable consumer. A 60-year-old non-pregnant female patient received second dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9267) via an unspecified route of administration in arm left on 17Feb2021 10:15 AM (at the age of 60-year-old) as dose 2, single for COVID-19 immunization. Medical history coronary artery disease (CAD). Patient has known allergies: NSAIDS, Artificial Sweeteners. The patient's concomitant medications were not reported.  The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient received other medications within 2 weeks of vaccination. Patient did not have covid prior vaccination and no covid tested post vaccination. Previously patient received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EL9265) via an unspecified route of administration in Arm Left on 26Jan2021 12:30 PM as dose 1, single dose for COVID-19 immunization. On 20Feb2021 at 8:00 AM patient experienced mid to upper back pain between shoulder bladed on both the left and right sides. Patient didn't received treatment for event. The outcome of the event was not recovered.  Follow-up (14May2021): Follow-up attempts completed. No further information expected.
Client had syncope episode with complaints of feeling cold, pallor, and dizziness after injection.  Legs were elevated onto chair. Vital signs, ice packs, water, and lollipop were provided. Client felt improvement in symptoms after ~12 minutes.  Client was escorted to observation area for an additional 15 mins of observation. Client left site at 10:51 AM in stable condition and steady gait. Educated client to follow up with PCP if symptoms persist.
chills; headaches; nauseated; so sick; Initial information received on 06-Dec-2022 regarding an unsolicited valid non-serious case received from a consumer.  This case involves an elderly patient of unknown gender who experienced chills, headaches, nauseated and so sick after receiving influenza vaccine.  It is unknown if the patient had any medical history, concomitant disease or risk factor. The patient's past medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient had received an unknown dose of suspect influenza vaccine produced by unknown manufacturer (strength, route, formulation, batch number and expiry date: unknown) in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed chills, headaches (headache), nauseated (nausea) and so sick (illness) (latency: unknown) following the administration of influenza vaccine.  It was reported that I have gotten a flu shot every year with no problems, last year got one, next day was so sick, chills, headaches and nauseated, felt that way for two days, then I find out there is the flu shot, then there is an extra strength flu shot for people 65 and over (which I am). So they gave me the stronger dose, that's why I felt sick!   It is unknown if there were lab data/results available.  Action taken: Not applicable.  It was not reported if the patient received a corrective treatment for the events.  At time of reporting, the outcome was unknown for all the events.
This spontaneous report as received from a 65 year old female registered nurse refers to herself. The patient received the first standard dose of PNEUMOVAX23 (Lot# and route not reported) vaccination 10 years ago in approximately May 2003. On 22-MAY-2013 the patient was vaccinated with the second dose of PNEUMOVAX23 (Lot# and route not reported). After receiving her second dose of PNEUMOVAX23 on 22-MAY-2013 the patient experienced significant arm pain. "It was hard but had no bruise". The patient also experienced a general feeling of malaise after vaccination. These symptoms lasted for a period of 48 hours before full recovery. Additional information has been requested.
Patient had noticeable swelling at the administration site. The area was also warm to the touch. No redness was present; there was only swelling.
101.1 fever, chills, headache, bodyache, nauseous, can't sleep, neck hurts, bruised up left arm, tired, lower back hurts, joints in both knees hurt.  All started at 1 am this morning.  Has lasted for 8 hours so far
This spontaneous report as received from a nurse practitioner refers to a female patient of unknown age. The patient was vaccinated with the first dose of GARDASIL (Lot # not reported) on 09-SEP-2011, second dose of GARDASIL (Lot # not reported) on 14-NOV-2012 and third dose of GARDASIL (Lot # not reported) on 14-JAN-2013. The nurse stated that even though the patient did not adhere to the GARDASIL recommended schedule she had not shown any symptoms of adverse reactions. Additional information has been requested.
He started feeling warm and seemed a little fussy on July 5 first thing in the morning. He started getting a higher temperature throughout the day with the highest at 101.9. He had a temperature even through part of the next day. He also started to get a rash throughout his body, and he was super tired on both days. The rash was light red dots all over his body. We went to the doctor on July 7 and saw an NP. We asked about the vaccine, and she said that it probably wasn't in relation since it had been past 4 days. She noted that he had an ear infection as well as some kind of virus because of the rash. Because of the ear infection, she gave us a prescription for Augmentin which was 3.5 mL for 10 days twice daily. He seems fine right now. He was fine temperature wise since the 7th and the rash is gone. It was only there for about a day or two, and the ear infection has also resolved. He also did have some decreased appetite and increased tiredness during this episode of events as well.
one of three pts were vaxed from the same vial & exp fever, fussiness & severe local reaction persisting @ time of this report 23APR; reporter states vial contains broken glass;
Had vomiting and diarrhea 8 days after receiving Rotavirus vaccine. No treatment needed.
Headaches, body aches, dizziness, and redness and swelling near injection site. Note: Injection sites are only 1cm apart.
Patient received Pfizer COVID booster in office administered by medical assistant. The following day, our vaccine coordinator was performing inventory on the COVID vaccines and discovered the entire vial of Pfizer vaccine was empty, though records show only one dose was administered out of that vial. She then reconciled the number of Pfizer vaccines with the number of accompanying vials of diluent and there was one more vial of diluent than there should have been. Based on that information, it is assumed that the patient received an undiluted dose of Pfizer vaccine as a booster, the equivalent of 7 doses.
getting covid; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Sep-2021 and was forwarded to Moderna on 08-Sep-2021.    This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (getting covid) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (getting covid). At the time of the report, COVID-19 (getting covid) outcome was unknown.            No concomitant drugs were reported. No treatment information was reported.   Reporter did not allow further contact
No adverse effects reported; The patient was administered PNEUMOVAX 23 who was improperly stored; This spontaneous report was received from a nurse, referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications and drug reactions or allergies were not provided.  On 15-MAY-2019, the patient was administered Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23) for prophylaxis (lot # R031812, expire date reported as 26-SEP-2020) (strength, dose, frequency and route were not reported) who was improperly stored. No adverse effects have been reported.   It was reported that the dose of Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23) underwent temperature excursions of 9 degrees Celsius (8.88 °C) for a time frame of 20 minutes, which was called by the digital data logger. There were no previous temperature excursions reported.
tested positive by home test last on 10Sep2022; tested positive by home test last on 10Sep2022; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), on 17Jan2021 as dose 1, single (Batch/Lot number: unknown), on 05Feb2021 as dose 2, single (Batch/Lot number: unknown) and on 29Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Arthritis" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 10Sep2022, outcome "unknown" and all described as "tested positive by home test last on 10Sep2022". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (10Sep2022) Positive, notes: home test. Clinical course: The patient has received 3 doses of the Pfizer COVID-19 vaccine on 17Jan2021, 05Feb2021, and 29Nov2021. She tested positive by home test last on 10Sep2022.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Tired; Arm hurt; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 20-May-2021 and was forwarded to Moderna on 20-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurt) and FATIGUE (Tired) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00621A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm hurt) and FATIGUE (Tired). At the time of the report, PAIN IN EXTREMITY (Arm hurt) and FATIGUE (Tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Treatment medications were unknown.
Very large hive on arm rt near injection site - hot - itchy - very sore arm and severe muscle aches for over 2 weeks.
patient says her arm near the injection site is red, sore,  swollen and warm to the touch.
EST. date of my delivery is  5/11/2021  30  hours after the dose had adnominal pain. Several episode of diarrhea. Also had nausea and chills.